{"name":"A2A Pharmaceuticals Inc.","slug":"a2a-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AO-252","genericName":"AO-252","slug":"ao-252","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AO-252","genericName":"AO-252","slug":"ao-252","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQjVVeml4TzVEVzdwTEw5c05xSjVlZ1NuSldhT0MwNnpNWS1nWUlodnBfY1duNFhua1JmNHFnX1RzMER4UXVPTU45OVFOcUt1RkV3bVUzc2NhOUUwYWc3WnlsYzZXNnBIY3V2QkxtVUpDZ2pjdE8wZ0lGUlZZZnZNSVFzcjMzcEJZVUZWUjRTVnBnVU5JcXdycnJlZG9ESW5pWjRicWs0SE81Qzg?oc=5","date":"2026-03-27","type":"deal","source":"Share Talk","summary":"Coiled Therapeutics plc (AIM: COIL) Admission to Trading and First Day of Dealings - Share Talk","headline":"Coiled Therapeutics plc (AIM: COIL) Admission to Trading and First Day of Dealings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5qMWJxeGJlajhta2UwbjhicnVVWmpqM3B2OUEtZ0RzU1BDTFJTMzZybUpRRU1yenFWMWhtMjc2MUxsOHk3ZmNreks2a1BtTzFxQXV1RXpmcnlkMXRN?oc=5","date":"2025-12-05","type":"pipeline","source":"Quiver Quantitative","summary":"BMEA | Biomea Fusion, Inc. Common Insider Trading - Quiver Quantitative","headline":"BMEA | Biomea Fusion, Inc. Common Insider Trading","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQZmUxekcwTjUtODlPSGpKUnNDQWJ6ZThiUFFINWg0cmJMYlpQeUtmbzNhUzJ2UDk0NXVkVUdDbkc3R2M2Z212M09ORFNGTEhrQlM3TFFLdGhDcTI1NERKLUI3WGIwaHpCRmRaRHVVS0NfMnZaQ1VxdldLY1VuNXBuU0k4SHg4V3FQYlhobk8zOE9ZSWFwZ191RkVrcDRwbFE4eEhzazFVXzRTbkF2dk1zQkxmRlhWSW9ZX293aFNvWDd2OXhoc2draDVLelVuQV9Td2VqdVdMaw?oc=5","date":"2025-11-18","type":"pipeline","source":"Proactive financial news","summary":"Roquefort jumps after securing global rights to cancer drug AO-252 | AIM:COIL - Proactive financial news","headline":"Roquefort jumps after securing global rights to cancer drug AO-252 | AIM:COIL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNXy02cHh5VkFHOEtjSktJZ0hTT3lNQmJVb0poekRESmhvZUJyMFFyTk1RNkJwVldhaklFZXdmc21fOGt5a3B2TVNwM2VSbWVZQ3BfNGVTMDhLVnNvN2gyY2dHb3hIbjl5X0J0TU03dEFjVWFGY2cwN2NZcTRrSXRWSUhDWkFWMnktRG9rUlNfN01MdHhaZ1h4RVU0OEg0RUpNcjJwU3hNMXVPVWUyQXVJZzM5bTdmc0ZKTm90a3VaRXRKNGNDVGZYQUZrZm85Wlo1WWFidFZOaWo4UFlF?oc=5","date":"2025-06-05","type":"pipeline","source":"24-7 Press Release Newswire","summary":"Marquis Who's Who Honors Winston Churchill for Expertise in the Pharmaceutical Sales Sector - 24-7 Press Release Newswire","headline":"Marquis Who's Who Honors Winston Churchill for Expertise in the Pharmaceutical Sales Sector - 24-7 Press Release Newswir","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOdllXdXhyOVhJbVhIakZLMWtPOXVQaHM0MWttTndDbDdDV1QzbzBUUDEtTHNpb193M3NYaFVkRGItUXp2NG1hdVRGUmoxR1hoRG5DOTJTY1BVSDJPMEZvU3ViQk1VVktqanVmQThqNW82ei1mSDFHT3Mycnh0dENsZjdfRVJDMHlXclQtOUFmemZSVWJIa3gyRnl3dUhaNWdHS2N5TV9NSHZiNHpSS3FsUWloTEdKdHJpUEFWVVFlMlM?oc=5","date":"2024-06-18","type":"pipeline","source":"Issuewire","summary":"Meet Sotirios Stergiopoulos, MD, MBEE, FACP: President, CEO, and Founder of A2A Pharma - Issuewire","headline":"Meet Sotirios Stergiopoulos, MD, MBEE, FACP: President, CEO, and Founder of A2A Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE8wd3BsZEx4YUtlOVdvbHNyQ3M4Z18ySTJtNV9nLTJtNXZHRDNHVjFVdHZTQWxzbnUtSkEyT1ZrUnAwV3BaS3JDY21pNm9STHZ1OTZIVmdWbzJEMWtLRm1xVEFxdmlnZnBCYVY2VmgtQnZ1LWxp?oc=5","date":"2023-10-23","type":"pipeline","source":"drugdiscoverytrends.com","summary":"A year in review: AI’s evolving role in drug discovery and development in 2023 - drugdiscoverytrends.com","headline":"A year in review: AI’s evolving role in drug discovery and development in 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOQVpNSVJNOTJudXBjenNfekNMeVV3RHlnQWJtY1hLM0tXLWRpT0I1c1hqVkhHd2Z6MVhxdjUzc0g3SW5vV1BzNS16WndsS2hsSnpTaThHa1ZHTmtvdlFHTnJUWEZHTTN5U0tEb0szMTloSmp4YThZUVF0aVVqZkZWR0JCbmx0a1FhMG5wMVEwdFpHVlJMVzBQNzd3ZHM5UGsyWEJ6eGZJYVlSZjFZbldlM0VpTFEwa1JzeEo4T2ZPeUtDMmRFelZfV1BpNUNYQ3B4S0IzRXItdVJrM09s?oc=5","date":"2023-07-27","type":"pipeline","source":"The Globe and Mail","summary":"Exscientia is the Sniper of the AI Drug Discovery Industry - The Globe and Mail","headline":"Exscientia is the Sniper of the AI Drug Discovery Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOOEJla09VaWtvc0FQalAwRnl0WWxaYS1wVnFyWWNRS2Fqc0pPNjFpcTRwdExEQWJmVko3ZzdhRVJKSGdqTkxWQ1VhV184dWxhaTh1UUtqbk1fTnpmbnJ3U18zZGt4TlFlenhoeU50Y3FvZU5oSWNYMXoyWlN6MnFKMGFKR3NhUzdzTkR4Y3dyLW1EbElpS0NMN1pNcEhMNno3U0RRNGRncENQX1pmUl9ROFJKU1BsZ1M1TDItQjQtdEdFTE1oTy1pN2JCY0pjLTkzUW82aF92SE4xblNSRFBvaFZXNTZZUGo2aE16YVB5N2ZiWmlpaUdiWDFTc2g2OHFwQ1NXNG4yQmFNYzFZcW5sSmljTjNNMXFIU0VBNU1LSQ?oc=5","date":"2020-06-08","type":"pipeline","source":"prnewswire.com","summary":"A2A Pharmaceuticals Collaborates With LAXAI Life Sciences to Co-develop SARS-CoV-2 Main Proteases Inhibitors for the Treatment of COVID-19 - prnewswire.com","headline":"A2A Pharmaceuticals Collaborates With LAXAI Life Sciences to Co-develop SARS-CoV-2 Main Proteases Inhibitors for the Tre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOYUIyckpwdzFrZks5eGp0NGV0VGtHS1pxcENNTjJNRy0tTElkN0NxNWs1WkxmVW5NQVU0T2NmaWRCeXFzRVZtX1gyV042TXBEdTRjcXBCMmtOU29FTG1fTG5JblJKandhRm8takM4eUVTRkRla1VjaF9yUEVqQkFwSjdOOWsyZjQyLTlnUjNHeUNlaVpxdTk2bHFlaWtsQXQtTlUxNnRFMVBrcDNxemdsWnFITExpX2lRbHRkQk9xcXV2NnIzOW9paHFzWi1sd1E?oc=5","date":"2019-07-02","type":"pipeline","source":"prnewswire.com","summary":"A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive Officer - prnewswire.com","headline":"A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive Officer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}